ES2082962T3 - Medicamentos y metodos de tratamiento del sindrome de inmunodeficiencia adquirida (sida) y del complejo relacionado con el sida (arc) que utilizan anticuerpos anti-carbohidrato. - Google Patents

Medicamentos y metodos de tratamiento del sindrome de inmunodeficiencia adquirida (sida) y del complejo relacionado con el sida (arc) que utilizan anticuerpos anti-carbohidrato.

Info

Publication number
ES2082962T3
ES2082962T3 ES91900749T ES91900749T ES2082962T3 ES 2082962 T3 ES2082962 T3 ES 2082962T3 ES 91900749 T ES91900749 T ES 91900749T ES 91900749 T ES91900749 T ES 91900749T ES 2082962 T3 ES2082962 T3 ES 2082962T3
Authority
ES
Spain
Prior art keywords
aids
arc
medicines
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900749T
Other languages
English (en)
Inventor
John-Erik Hansen
Henrik Clausen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bay Development Corp SA
Original Assignee
Bay Development Corp SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bay Development Corp SA filed Critical Bay Development Corp SA
Application granted granted Critical
Publication of ES2082962T3 publication Critical patent/ES2082962T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UN ANTICUERPO MONOCLONAL O DE OTRA CLASE AL ANTIGENO TN DEL CARBOHIDRATO PUEDE USARSE PARA INHIBIR O DECELERAR LA PROGRESION DEL SIDA O DEL ARC. EL ANTIGENO PUEDE USARSE EN UNA VACUNA PARA CONSEGUIR LA INMUNIZACION.
ES91900749T 1990-01-26 1990-12-13 Medicamentos y metodos de tratamiento del sindrome de inmunodeficiencia adquirida (sida) y del complejo relacionado con el sida (arc) que utilizan anticuerpos anti-carbohidrato. Expired - Lifetime ES2082962T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47066690A 1990-01-26 1990-01-26

Publications (1)

Publication Number Publication Date
ES2082962T3 true ES2082962T3 (es) 1996-04-01

Family

ID=23868522

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900749T Expired - Lifetime ES2082962T3 (es) 1990-01-26 1990-12-13 Medicamentos y metodos de tratamiento del sindrome de inmunodeficiencia adquirida (sida) y del complejo relacionado con el sida (arc) que utilizan anticuerpos anti-carbohidrato.

Country Status (10)

Country Link
EP (2) EP0511967B1 (es)
JP (2) JPH05506565A (es)
AT (1) ATE134649T1 (es)
AU (1) AU653141B2 (es)
CA (2) CA2074512A1 (es)
DE (1) DE69025629T2 (es)
ES (1) ES2082962T3 (es)
FI (1) FI923348A0 (es)
NO (1) NO922941L (es)
WO (2) WO1991011528A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2044741A1 (en) * 1990-06-18 1991-12-19 Jade Chin Hiv gp120 monoclonal antibodies
US6800468B1 (en) 1998-11-13 2004-10-05 Henrik Clausen UDP-galactose: β-N-acetyl-glucosamine β1,3galactosyltransferases, β3Gal-T5
ATE408006T1 (de) 1998-11-13 2008-09-15 Henrick Clausen Udp-galaktose: beta-i(n)-acetyl-glukosamin beta1, 3 galaktosyltransferasen, beta3gal-t5
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット
DE68922806T2 (de) * 1988-03-11 1996-02-29 Biomembrane Inst Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden-trägerkonjugaten.

Also Published As

Publication number Publication date
WO1991011528A1 (en) 1991-08-08
DE69025629T2 (de) 1996-07-04
WO1991011199A1 (en) 1991-08-08
CA2073459A1 (en) 1991-07-27
NO922941D0 (no) 1992-07-24
CA2074512A1 (en) 1991-07-27
EP0512023A4 (en) 1993-06-30
EP0511967B1 (en) 1996-02-28
NO922941L (no) 1992-09-17
DE69025629D1 (de) 1996-04-04
FI923348A (fi) 1992-07-23
ATE134649T1 (de) 1996-03-15
AU653141B2 (en) 1994-09-22
FI923348A0 (fi) 1992-07-23
JPH05506843A (ja) 1993-10-07
EP0511967A1 (en) 1992-11-11
JPH05506565A (ja) 1993-09-30
AU6961491A (en) 1991-08-21
EP0512023A1 (en) 1992-11-11

Similar Documents

Publication Publication Date Title
NO944475L (no) Kombinerte vaksiner omfattende Hepatit B overflateantigen og andre antigener
ES2166779T3 (es) Complejos inmunogenicos del hiv.
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
NO863803D0 (no) Vaksiner og immunoanalyser for ervervet immunsviktsyndrom (aids).
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
GB2255093A (en) Hiv-1 core protein fragments
FI931393A0 (fi) Peptider foer anvaendning vid vaccinering och induktion av neutraliserande motkroppar mot humant immunbristvirus
FR2599626B1 (fr) Antigene du flavivirus, procede pour sa production et vaccin le contenant
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
ES2082962T3 (es) Medicamentos y metodos de tratamiento del sindrome de inmunodeficiencia adquirida (sida) y del complejo relacionado con el sida (arc) que utilizan anticuerpos anti-carbohidrato.
IT1254360B (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
NZ223980A (en) An aids-type virus vaccine comprising an antibody equivalent which recognises an epitope on a cd4 cell-marker
JPS6463392A (en) Monoclonal antibody against specific antigen for human immunodeficiency virus
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
ES2066753T3 (es) Uso de un preparado, que contiene inmunoglobulina, para la profilaxis y la terapia del sida, en personas.
DE3482813D1 (de) Adult t-zell-leukemiavirus-antigenpeptid.
ITRM910546A1 (it) Epitopi della proteina env del virus dell'epatite c.
NO890565L (no) Forhindring og behandling av retroviral sykdom.
FR2608926B1 (fr) Antigene de babesia divergens, procede pour le produire et vaccin le contenant
ZA916313B (en) New use of a monoclonal antibody
ES2073569T3 (es) Anticuerpo monoclonal contra la proteina c reactiva.
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
DE3777196D1 (de) Anti-parathyroid-antikoerper-praeparat.
MX9201711A (es) Metodo para retardar y reducir la aparicion del virus resistente a analogos de nucleosidos, en un paciente que tiene una infeccion por vih.
FR2655853B1 (fr) Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 511967

Country of ref document: ES